SCHEMBL29323570

SCHEMBL29323570

C=C(C)CCCCCC(CCCCCC)CCCCCCCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.52
FFAR4 Q5NUL3 2/20 0.42
FFAR1 O14842 2/20 0.42
CES2 O00748 3/20 0.39
CES1 P23141 3/20 0.39
GPR84 Q9NQS5 7/20 0.38
PPARG P37231 6/20 0.38
PPARD Q03181 6/20 0.38
PPARA Q07869 6/20 0.38
HDAC11 Q96DB2 5/20 0.38
TSHR P16473 4/20 0.38
ALDH1A1 P00352 2/20 0.38
TLR2 O60603 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
FABP4 P15090 2/20 0.38
PTPN1 P18031 2/20 0.38
SLC22A6 Q4U2R8 1/20 0.38
SLC22A8 Q8TCC7 1/20 0.38
MEN1 O00255 1/20 0.38
ESR1 P03372 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24375710 0.91 LMNA (0.44) LMNAFFAR4FFAR1TSHRALDH1A1
SCHEMBL1904679 0.88 TSHR (0.53) LMNAFFAR4FFAR1PPARGTSHR
SCHEMBL1901451 0.88 TSHR (0.53) LMNAFFAR4FFAR1PPARGTSHR
SCHEMBL1905194 0.88 TSHR (0.53) LMNAFFAR4FFAR1PPARGTSHR
SCHEMBL1901214 0.88 TSHR (0.53) LMNAFFAR4FFAR1PPARGTSHR
SCHEMBL1907176 0.88 TSHR (0.53) LMNAFFAR4FFAR1PPARGTSHR
SCHEMBL3188281 0.86 CES2 (0.50) FFAR4FFAR1CES2CES1GPR84
SCHEMBL1276219 0.86 CES2 (0.50) FFAR4FFAR1CES2CES1GPR84
SCHEMBL21834650 0.86 CES2 (0.50) FFAR4FFAR1CES2CES1GPR84
SCHEMBL1261681 0.86 CES2 (0.50) FFAR4FFAR1CES2CES1GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4400491-A1 NOVEL LIPIDS USED FOR NUCLEIC ACID DELIVERY AND LIPID NANOPARTICLE COMPOSITION Themedium Therapeutics Co., Ltd (CN) 2024-07-17 EP disclosed